
A biocatalytic platform leveraging cytochrome P450 activity expressed in a non-conventional yeast host, enabling selective oxidative transformations — including regioselective and stereoselective hydroxylation — under mi...
A development programme producing recombinant monoclonal antibodies and related biological therapeutics for veterinary applications, manufactured via a non-conventional yeast expression platform. Initial focus on compani...
A novel capture purification technology designed as a lower-cost alternative to traditional affinity resin-based primary recovery for recombinant proteins and biologics. Format-flexible and integrable into existing downs...